Astrazeneca (AZN) EBT Margin (QoQ) (2009 - 2026)
Astrazeneca (AZN) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.51 Bn | 632.75 Bn | 17.26 Bn |
| 2 | AbbVie | 470.18 Bn | 463.61 Bn | 12.70 Bn |
| 3 | Merck | 376.85 Bn | 369.71 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.27 Bn | 295.58 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.42 Bn | 252.52 Bn | 12.86 Bn |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.16 Bn | 178.98 Bn | 6.22 Bn |
| 8 | Pfizer | 159.30 Bn | 147.60 Bn | 10.94 Bn |
| 9 | Gsk | 106.12 Bn | 101.95 Bn | 8.24 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -506,431.00 |
| Mar 31, 2026 | -3.87 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 2.95 Mn |
| Jun 30, 2025 | -457,269.00 |
| Mar 31, 2025 | 439,288.00 |
| Dec 31, 2024 | -289,389.00 |
| Sep 30, 2024 | -5.68 Mn |
| Jun 30, 2024 | 5.37 Mn |
| Mar 31, 2024 | 432,885.00 |
| Dec 31, 2023 | 19,028.00 |
| Sep 30, 2023 | 62,123.00 |
| Jun 30, 2023 | -729,591.00 |
| Mar 31, 2023 | 788,537.00 |
| Dec 31, 2022 | -2,557.00 |
| Sep 30, 2022 | -771,536.00 |
| Jun 30, 2022 | 801,899.00 |
| Mar 31, 2022 | 33,832.00 |
| Dec 31, 2021 | 147,682.00 |
| Sep 30, 2021 | -203,737.00 |